Hi Rob
It's always a bit difficult to pin down what makes a LIC trade at a discount. There are a lot of factors. It may be length of track record, their performance, the fee structure, their size and liquidity, their capital structure, the level of market confidence in the strategy, the board or the investment manager. It may also be that the increase in NTA is just not being matched by the interest in their shares. It's not easy to pin down. In the case of HML, personally I suspect it's a combination of options overhang, lack of transparency around the investment portfolio and the corporate structure of the investment manager. But ultimately, to get the answer, you need to read the collective mind of the rest of the market!
- Forums
- ASX - By Stock
- HML
- Ann: Net Tangible Asset Backing
Ann: Net Tangible Asset Backing, page-48
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HML (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online